Recursion Pharmaceuticals (RXRX) stock rises after J.P. Morgan upgraded the biotech, citing a $1B+ sales potential for the ...

RXRX remains down by 35% year-to-date and is trading below $5. Thus, the critical question isn’t about a single good ...

Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Lawmakers split after viewing boat strike video: Democrat calls it 'one of the most troubling ...

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Three recent graduates from the MSU photo program noticed a glaring gap in the photo-journal world. While there has been ...

Fundamental concepts of computers, computation and programming; history and principles of computing; problem solving; input, output; data representation, storage, and file organization; computer ...

The simulation hypothesis — the idea that our universe might be an artificial construct running on some advanced alien ...

One of the most significant insights from the study is that roboticists must engage both technically and physically with ...

With the popularity of AI coding tools rising among some software developers, their adoption has begun to touch every aspect ...